APA (7th ed.) Citation

Montoro, J., Roldán, E., Piñana, J. L., Barba, P., Chorão, P., Quintero, A., . . . Valcárcel, D. (2021). Ex vivo T‐cell depletion vs post‐transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft‐vs‐host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. European Journal of Haematology, 106(1), 114. https://doi.org/10.1111/ejh.13529

Chicago Style (17th ed.) Citation

Montoro, Juan, et al. "Ex Vivo T‐cell Depletion Vs Post‐transplant Cyclophosphamide, Sirolimus, and Mycophenolate Mofetil as Graft‐vs‐host Disease Prophylaxis for Allogeneic Hematopoietic Stem Cell Transplantation." European Journal of Haematology 106, no. 1 (2021): 114. https://doi.org/10.1111/ejh.13529.

MLA (9th ed.) Citation

Montoro, Juan, et al. "Ex Vivo T‐cell Depletion Vs Post‐transplant Cyclophosphamide, Sirolimus, and Mycophenolate Mofetil as Graft‐vs‐host Disease Prophylaxis for Allogeneic Hematopoietic Stem Cell Transplantation." European Journal of Haematology, vol. 106, no. 1, 2021, p. 114, https://doi.org/10.1111/ejh.13529.